CSUI (Cannabis Suisse) EBIT : $-1.62 Mil (TTM As of Aug. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cannabis Suisse EBIT?

Cannabis Suisse's earnings before interest and taxes (EBIT) for the three months ended in Aug. 2024 was $-0.52 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Aug. 2024 was $-1.62 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cannabis Suisse's annualized ROC % for the quarter that ended in Aug. 2024 was -31.35%. Cannabis Suisse's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2024 was -263.29%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cannabis Suisse's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2024 was -37.59%.

Cannabis Suisse EBIT Historical Data

The historical data trend for Cannabis Suisse's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Suisse EBIT Chart

Cannabis Suisse Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

May24

EBIT

Get a 7-Day Free Trial

-0.39

-0.35

-0.12

-0.34

-1.16

Cannabis Suisse Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
EBIT	Get a 7-Day Free Trial															-0.06	-0.05	-0.06	-0.99	-0.52

Competitive Comparison of Cannabis Suisse's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Suisse's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Suisse's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Suisse's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabis Suisse's EV-to-EBIT falls into.

Cannabis Suisse EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.62 Mil.

Cannabis Suisse (OTCPK:CSUI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cannabis Suisse's annualized ROC % for the quarter that ended in Aug. 2024 is calculated as:

	ROC % (Q: Aug. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: May. 2024 )	+	Invested Capital (Q: Aug. 2024 ))	/ count )
=	-0.3 * ( 1 - 0% )	/	( (1.044	+	0.87)	/ 2 )
=	-0.3	/	0.957
=	-31.35 %

where

	Invested Capital		(Q: May. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.897	-	0.038	-	( 0	-	max(0, 0.381	-	0.196	+	0	))
=	1.044

	Invested Capital		(Q: Aug. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.834	-	0.026	-	( 0	-	max(0, 0.237	-	0.175	+	0	))
=	0.87

Note: The Operating Income data used here is four times the quarterly (Aug. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Cannabis Suisse's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Aug. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: May. 2024		Q: Aug. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-2.08	/	( ( (0.7 + max(0.075, 0))	+	(0.659 + max(0.146, 0)) )	/	2 )
=	-2.08	/	( ( 0.775	+	0.805 )	/	2 )
=	-2.08	/	0.79
=	-263.29 %

where Working Capital is:

	Working Capital		(Q: May. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.196)	-	(0.038	+	0.083	+	0)
=	0.075

	Working Capital		(Q: Aug. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.175)	-	(0.026	+	0.003	+	0)
=	0.146

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Aug. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cannabis Suisse's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Aug. 2024 )
	=	-1.62	/	4.310
	=	-37.59 %

Cannabis Suisse EBIT Related Terms

Thank you for viewing the detailed overview of Cannabis Suisse's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.